Nuvpreet S Bhandal, MD
Sports Medicine · Lodi
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 11 years
- University of Missouri, Kansas City, School of Medicine, 2015
Offices
2 locations · Adventist Health Physicians Network · 628 clinicians in this group
Hospitals listed: Adventist Health Lodi Memorial. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bhandal’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A172631 · Current
Licensed to practise in California · since 2021 · expires 2027-05-31 · University of Missouri-Kansas City School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Orthopaedic Surgery - Orthopaedic Surgery
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Lodi MemorialLodi, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.222, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Lodi Memorial
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 6 the same, 0 worse of 6 measures. Readmissions: 1 better, 3 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.222 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.16 to 2.22) · 678 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.59 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 203.28 (143.15 to 263.4) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 43 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 334 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 570 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.9 · 184 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 1,823 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.02 to 0.45) · 4,072 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.08 to 0.49) · 4,094 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.18 (0.83 to 5.53) · 476 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.34) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.8 to 4.13) · 448 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.29 (0 to 17.86) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 78 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.16) · 142 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.74 (0 to 1.53) · 3,347 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.368 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.655 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.506 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 27 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 450 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 47.3 · 381 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.2 · 604 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.1 · 661 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.9 · 188 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.6 (8.9 to 15.2) · 932 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 449 cases | No different | Jan 2024 – Dec 2024 |
What patients said (438 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 79% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$76,807
Medicare paid this office $76,807 for 289 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 99 | $8,217 | $69 |
| Return visit (30+ min) | 60 | $7,204 | $103 |
| New patient visit (30+ min) | 88 | $6,734 | $77 |
| Aspiration and/or injection of fluid from large joint | 86 | $5,704 | $53 |
| New patient visit (45+ min) | 53 | $5,486 | $104 |
See all 11 services
| Short return visit (20+ min) | 99 | $8,217 | $69 |
| Return visit (30+ min) | 60 | $7,204 | $103 |
| New patient visit (30+ min) | 88 | $6,734 | $77 |
| Aspiration and/or injection of fluid from large joint | 86 | $5,704 | $53 |
| New patient visit (45+ min) | 53 | $5,486 | $104 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $1,933 | $138 |
| Long return visit (40+ min) | 12 | $1,760 | $147 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,328 | $102 |
| Injection, methylprednisolone acetate, 1 mg | 59 | $465 | None |
| X-ray of shoulder, minimum of 2 views | 14 | $329 | $23 |
| Injection, methylprednisolone acetate, 40 mg | 19 | $252 | None |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Removal of tissue | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 13 | More than 51% of doctors who do this |
Procedures year by year
| Procedure | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | – | 77 | 136 | 107 |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | – | – | 11 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
289 Original Medicare patients in 2024. Average age 73 · Under 65 14% · 85 and older 17% · Women 66% · Also on Medicaid 43% · Health risk score 1.31. Sicker patients than 9 in 10 peers; the typical sports medicine clinician is at 1.05.
Conditions among them: High blood pressure 75% · Diabetes 32% · Depression 28% · Coronary heart disease 22% · Chronic kidney disease 22% · Heart failure 16% · COPD 16% · Atrial fibrillation 14% · Cancer 13% · Stroke 8% · Dementia 5%.
The office billed $296,248, Medicare allowed $103,007 and paid $76,807; for 6,355 services of 73 kinds; $4,341 of it was for drugs given in the office and $72,466 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 289 | 6,355 | 73 | 1.31 | $296,248 | $76,807 |
| 2023 | 301 | 2,859 | 72 | 1.10 | $430,369 | $103,302 |
| 2022 | 211 | 2,326 | 73 | 1.39 | $248,034 | $68,018 |
| 2021 | 45 | 193 | 74 | 1.32 | $48,968 | $15,367 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| New patient visit (45+ min) | 88 | $11,263 | $128 |
| Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 23 | $10,852 | None |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | 11 | $10,767 | $979 |
| Short return visit (20+ min) | 102 | $10,608 | $71 |
| Aspiration and/or injection of fluid from large joint | 85 | $7,444 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $5,822 | $142 |
| New patient visit (30+ min) | 70 | $5,052 | $72 |
| Return visit (30+ min) | 36 | $3,964 | $104 |
| X-ray of knee, 4 or more views | 22 | $993 | $35 |
| Injection, methylprednisolone acetate, 40 mg | 43 | $653 | None |
| X-ray of shoulder, minimum of 2 views | 15 | $525 | $28 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 31 | $259 | None |
2022: 9 services
| New patient visit (45+ min) | 74 | $9,652 | $130 |
| Short return visit (20+ min) | 70 | $6,587 | $70 |
| Aspiration and/or injection of fluid from large joint | 50 | $4,363 | $57 |
| New patient visit (30+ min) | 48 | $4,108 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $1,863 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,762 | $160 |
| Return visit (30+ min) | 14 | $1,598 | $107 |
| Injection, methylprednisolone acetate, 40 mg | 19 | $712 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | $202 | None |
2021: 2 services
| New patient visit (45+ min) | 25 | $3,471 | $139 |
| Short return visit (20+ min) | 11 | $1,209 | $76 |
Medicaid work
$8,973 in 2024
Medicaid paid $8,973 for 532 billed services this clinician did in 2024, up to 41 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 117 | $2,738 |
| Short return visit (20+ min) | 175 | $2,477 |
| New patient visit (45+ min) | 76 | $1,831 |
| Arthrocentesis and injection of knee joint | 111 | $1,080 |
| Return visit (30+ min) | 13 | $662 |
| Injection, methylprednisolone acetate, 1 mg | 16 | $110 |
| Injection, methylprednisolone acetate, 40 mg | 24 | $76 |
| 2024 | 532 | 7 | 41 | $8,973 |
| 2023 | 1,129 | 6 | 56 | $3,125 |
| 2022 | 881 | 6 | 47 | $1,357 |
| 2021 | 138 | 2 | 41 | $191 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 282 | $1,431 |
| Short return visit (20+ min) | 326 | $636 |
| New patient visit (30+ min) | 204 | $561 |
| Arthrocentesis and injection of knee joint | 242 | $313 |
| Return visit (30+ min) | 29 | $153 |
| Injection, methylprednisolone acetate, 40 mg | 46 | $31 |
2022
| Short return visit (20+ min) | 320 | $534 |
| New patient visit (30+ min) | 118 | $436 |
| New patient visit (45+ min) | 272 | $377 |
| Arthrocentesis and injection of knee joint | 141 | $9 |
| Return visit (30+ min) | 18 | $0 |
| Injection, methylprednisolone acetate, 40 mg | 12 | $0 |
2021
| Short return visit (20+ min) | 47 | $120 |
| New patient visit (45+ min) | 91 | $71 |
Drugs they prescribed that Part D paid
$1,040
Pharmacies billed $1,040 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 43% of their Part D prescriptions (52 of 120) in 2024. A higher opioid share than 9 in 10 peers; the typical sports medicine clinician is at 15%.
120 generic and 0 brand-name prescriptions · $1,040 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ondansetron Odt | 15 | $274 | $18 |
| Hydrocodone-Acetaminophen | 26 | $190 | $7 |
| Ibuprofen | 16 | $92 | $6 |
| Meloxicam | 17 | $61 | $4 |
| Tramadol | 17 | $54 | $3 |
Year by year
| 2024 | 120 | 51 | 43% (52) | 0% | $1,040 |
| 2023 | 164 | 72 | 32% (53) | None | $2,031 |
| 2022 | 201 | 80 | 16% (33) | 0% | $2,458 |
| 2021 | 12 | None | 0% (0) | 0% | $218 |
| 2020 | 28 | 17 | 54% (15) | None | $1,481 |
| 2019 | 95 | 53 | 54% (51) | None | $5,526 |
| 2018 | 83 | 50 | 55% (46) | None | $1,839 |
| 2017 | 87 | 53 | 66% (57) | 15% | $4,875 |
| 2016 | 82 | 63 | 82% (67) | None | $1,945 |
| 2015 | 22 | 18 | 68% (15) | None | $1,014 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Diclofenac | 21 | $520 | $25 |
| Meloxicam | 58 | $501 | $9 |
| Hydrocodone-Acetaminophen | 25 | $245 | $10 |
| Ondansetron Odt | 19 | $243 | $13 |
| Oxycodone | 16 | $86 | $5 |
2022: 3 drugs
| Diclofenac | 37 | $1,038 | $28 |
| Meloxicam | 101 | $600 | $6 |
| Ondansetron Odt | 15 | $373 | $25 |
2019: 1 drug
| Oxycodone-Acetaminophen | 28 | $275 | $10 |
2018: 2 drugs
| Oxycodone-Acetaminophen | 19 | $198 | $10 |
| Oxycodone | 15 | $87 | $6 |
2017: 4 drugs
| Enoxaparin | 12 | $3,263 | $272 |
| Oxycodone | 20 | $177 | $9 |
| Hydrocodone-Acetaminophen | 13 | $134 | $10 |
| Tramadol | 16 | $92 | $6 |
2016: 4 drugs
| Oxycodone | 20 | $436 | $22 |
| Hydrocodone-Acetaminophen | 23 | $402 | $17 |
| Oxycodone-Acetaminophen | 11 | $196 | $18 |
| Tramadol | 13 | $108 | $8 |
Money from drug and device companies
$443 in 2025
| 2025 | 7 | 11 | None | $443 |
| 2024 | 7 | 11 | None | $390 |
| 2023 | 9 | 13 | None | $460 |
| 2022 | 9 | 14 | None | $10,240 |
| 2021 | 6 | 37 | None | $7,990 |
| 2020 | 1 | 2 | None | $276 |
| 2019 | 1 | 1 | None | $1,325 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Pangea | $185 | 2 payments
|
| Smith+Nephew | Bioinductive Implant With Arthroscopic Delivery System - Medium | $70 | 1 payment
|
| MIMEDX Group | None | $57 | 2 payments
|
| Amgen | Krystexxa | $50 | 2 payments
|
| Vertex Pharmaceuticals | Journavx | $43 | 2 payments
|
| Solventum | Prevena | $20 | 1 payment
|
See all 11 published payments
| Smith+Nephew | Meals · 2025-11-25 | Bioinductive Implant With Arthroscopic Delivery System - Medium | $70 |
| Cornerstone Medical Associates | Meals · 2025-11-14 | None | $17 |
| Vertex Pharmaceuticals | Meals · 2025-11-13 | Journavx | $26 |
| Solventum | Meals · 2025-11-04 | Prevena | $20 |
| MIMEDX Group | Meals · 2025-10-08 | None | $14 |
| Vertex Pharmaceuticals | Meals · 2025-10-02 | Journavx | $17 |
| Amgen | Meals · 2025-07-29 | Krystexxa | $29 |
| MIMEDX Group | Meals · 2025-06-17 | None | $43 |
| Amgen | Meals · 2025-06-03 | Krystexxa | $21 |
| Stryker | Meals · 2025-01-28 | Pangea | $141 |
| Stryker | Meals · 2025-01-20 | Tornier Perform Reversed Augmented Glenoid | $44 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $390
| Stryker | Aequalis Perform Reversed | $122 | 2 payments
|
| Smith+Nephew | Evos | $70 | 2 payments
|
| Cornerstone Medical Associates | None | $69 | 1 payment
|
| Evolution Surgical | None | $58 | 2 payments
|
| Biotissue Holdings | None | $37 | 2 payments
|
| ConvaTec | Aquacel Ag+ Extra | $21 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $14 | 1 payment
|
2023: $460
| Stryker | Aequalis Flex Revive | $126 | 3 payments
|
| Globus Medical | Mini Fragment System | $118 | 3 payments
|
| DePuy Synthes Sales | Tfn-Advance | $67 | 1 payment
|
| Sanofi-Aventis U.S. | Synvisc-One | $34 | 1 payment
|
| Smith+Nephew | Bone Anchors With Arthroscopic Delivery System | $33 | 1 payment
|
| Medtronic | Intellis Adaptivestim | $23 | 1 payment
|
| ConvaTec | Aquacel Ag+ Extra | $22 | 1 payment
|
| Vericel | Maci | $20 | 1 payment
|
| Milliken Healthcare Products | Coflex Tlc | $17 | 1 payment
|
2022: $10,240
| Smith+Nephew | None | $5,000 | 1 payment
|
| Sequoia Surgical | None | $2,424 | 4 payments
|
| Evolution Surgical | None | $1,200 | 1 payment
|
| Cornerstone Medical Associates | None | $1,200 | 1 payment
|
| Stryker | Gravity Synchfix | $178 | 2 payments
|
| Davol | Arista Ah Flexitip | $140 | 1 payment
|
| Bioventus | None | $48 | 2 payments
|
| DePuy Synthes Sales | Tfn-Advance | $36 | 1 payment
|
| Alfasigma USA | None | $15 | 1 payment
|
2021: $7,990
| Arthrex | None | $4,841 | 23 payments
|
| Sequoia Surgical | None | $2,442 | 5 payments
|
| Gotham Surgical Solutions & Devices | None | $274 | 2 payments
|
| Stryker | Triathlon | $234 | 4 payments
|
| DePuy Synthes Sales | Dynacord | $185 | 2 payments
|
| Bioventus | Exogen Ultrasound Bone Healing System | $14 | 1 payment
|
2020: $276
| Acumed | Anatomic Radial Head System | $276 | 2 payments
|
2019: $1,325
| Rock Medical Orthopedics | None | $1,325 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1205222445
- Licence
- CA A172631California A172631: Current · expires 2027-05-31
- Trained
- University of Missouri, Kansas City, School of Medicine, 2015 · 11 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207XX0005X (207XX0005X)
- Mailing address
- 6620 Coyle Avenue, Ste 202, Carmichael, CA, 95608
- NPI first listed
- 2015-04-14
- NPI last updated
- 2021-08-09
- NPI record certified
- 2021-08-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 576 Sunrise Avenue, Roseville, CA, 95661